Evidence map›Paper›PMID 33256836›Full record

ArticleActa neuropathologica communications2020

Down syndrome cell adhesion molecule like-1 (DSCAML1) links the GABA system and seizure susceptibility.

Yoneko Hayase, Shigeru Amano, Koichi Hashizume, Takashi Tominaga, Hiroyuki Miyamoto, Yukie Kanno, Yukiko Ueno-Inoue, Takayoshi Inoue, Mayumi Yamada, Shigehiro Ogata and 23 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Deficiency in the cell-adhesion moleculeFrontiers in cell and developmental biology · 2023
    Article
  3. Article
  4. Assessing seizure liabilityFrontiers in cellular neuroscience · 2023
    Article
  5. Rat Models of Human Diseases and Related Phenotypes: A Novel Inventory of Causative Genes.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 12 institutions in 1 country.

Yoneko HayaseDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan. yhayase887@yahoo.co.jp.ORCID 0000-0002-0638-2850
Shigeru AmanoGraduate School of Medicine Faculty of Health Science, Department of Laboratory Medicine, Kyoto University, Kyoto, 606-8501, Japan.
Koichi HashizumeDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Takashi TominagaLaboratory for Neural Circuit System, Institute of Neuroscience, Tokushima Bunri University, Sanuki, 769-2300, Japan.
Hiroyuki MiyamotoInternational Research Center for Neurointelligence (IRCN), The University of Tokyo, Tokyo, 187-8502, Japan.
Yukie KannoDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Yukiko Ueno-InoueDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Takayoshi InoueDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Mayumi YamadaResearch Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Kyoto, 606-8501, Japan.
Shigehiro OgataDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Shabeesh BalanLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
Ken HayashiDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Yoshiki MiuraDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Kentaro TokudomeDepartment of Pharmacology, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, 569-1094, Japan.
Yukihiro OhnoDepartment of Pharmacology, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, 569-1094, Japan.
Takuma NishijoDepartment of Pharmacology, Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Toshihiko MomiyamaDepartment of Pharmacology, Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Yuchio YanagawaGenetic and Behavioral Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.
Akiko TakizawaInstitute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
Tomoji MashimoInstitute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
Tadao SerikawaInstitute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan.
Akihiro SekineOmics-Based Medicine, Center for Preventive Medical Science, Chiba University, Chiba, 260-0856, Japan.
Eiji NakagawaDepartment of Pediatric Neurology, National Center Hospital, NCNP, Tokyo, 187-8551, Japan.
Eri TakeshitaDepartment of Pediatric Neurology, National Center Hospital, NCNP, Tokyo, 187-8551, Japan.
Takeo YoshikawaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
Chikako WagaDepartment of Mental Retardation and Birth Defect Research, NCNP, Tokyo, 187-8551, Japan.
Ken InoueDepartment of Mental Retardation and Birth Defect Research, NCNP, Tokyo, 187-8551, Japan.
Yu-Ichi GotoDepartment of Mental Retardation and Birth Defect Research, NCNP, Tokyo, 187-8551, Japan.
Yoichi NabeshimaFoundation for Biomedical Research and Innovation, Kobe, 650-0047, Japan.
Nobuo IharaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan.
Kazuhiro YamakawaGraduate School of Medical Science, Nagoya City University, Nagoya, 467-8601, Japan.
Shinichiro TayaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan. s-taya@ncnp.go.jp.
Mikio HoshinoDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo, 187-8502, Japan. hoshino@ncnp.go.jp.
National Center of Neurology and Psychiatry · JPKyoto University · JPJikei University School of Medicine · JPOsaka University of Pharmaceutical Sciences · JPRIKEN Center for Brain Science · JPChiba University · JPFoundation for Biomedical Research and Innovation · JPGunma University · JPNagoya City University · JPThe University of Tokyo · JPTokushima Bunri University · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ihara epileptic rat (IER) is a mutant model with limbic-like seizures whose pathology and causative gene remain elusive. In this report, via linkage analysis, we identified Down syndrome cell adhesion molecule-like 1(Dscaml1) as the responsible gene for IER. A single base mutation in Dscaml1 causes abnormal splicing, leading to lack of DSCAML1. IERs have enhanced seizure susceptibility and accelerated kindling establishment. Furthermore, GABAergic neurons are severely reduced in the entorhinal cortex (ECx) of these animals. Voltage-sensitive dye imaging that directly presents the excitation status of brain slices revealed abnormally persistent excitability in IER ECx. This suggests that reduced GABAergic neurons may cause weak sustained entorhinal cortex activations, leading to natural kindling via the perforant path that could cause dentate gyrus hypertrophy and epileptogenesis. Furthermore, we identified a single nucleotide substitution in a human epilepsy that would result in one amino acid change in DSCAML1 (A2105T mutation). The mutant DSCAML1

Indexed as

AnimalsCell Adhesion MoleculesElectroencephalographyEntorhinal CortexGABAergic NeuronsGenetic Predisposition to DiseaseKindling, NeurologicMiceRatsRats, Mutant StrainsSeizuresCell Adhesion MoleculesDSCAML1 protein, mouseDSCAML1Gabaergic neuronsIhara epileptic ratPatient-type model mouseSeizure susceptibility

Identifiers

PMID33256836
PMCPMC7706048
OpenAlexW3106800060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.